Skip to content

ClearPoint Neuro CLPT Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$29.07M-13.8%-$25.54M-10.4%-$23.14M-4.1%-$22.22M-6.9%-$20.79M-9.9%
$797K-2.1%$814K+1.1%$805K-19.7%$1M+19.4%$840K-14.3%
$8.49M+3.8%$8.18M+3.5%$7.9M+1.5%$7.78M+6.5%$7.31M+5.8%
-$25.7M-7.5%-$23.9M-82.6%-$13.09M-17.2%-$11.17M+1.0%-$11.28M-26.1%
$984K+88.5%$522K-29.1%$736K+34.1%$549K+19.9%$458K+66.5%
$1.14M+33.3%$852.75K+50.0%$568.5K+100%$284.25K
$153K-75.1%$615K+184%-$736K-34.1%-$549K-19.9%-$458K-66.5%
$49.7M-1.0%$50.18M+63.7%$30.65M
$8.88M+139%-$22.97M-656%
-$26.68M-9.2%-$24.42M-76.7%-$13.82M-18.0%-$11.72M+0.2%-$11.74M-27.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does ClearPoint Neuro generate?
ClearPoint Neuro (CLPT) generated -$25.7M in operating cash flow over the trailing twelve months.
What is ClearPoint Neuro's free cash flow?
After $984.0K of capital expenditures, ClearPoint Neuro's free cash flow was -$26.7M over the trailing twelve months, down 127.3% year over year.
Where does ClearPoint Neuro's cash flow data come from?
Every line is extracted from ClearPoint Neuro's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.